Onyx Scientific, the CDMO division of Ipca Laboratories, has specialized in small molecule drug substance development and manufacturing for 25 years. From our MHRA-licensed facilities in the UK, we provide seamless support for early development for candidate APIs, clinical phase production, and commercial supply. Our dedicated solid-state and analytical chemistry teams accelerate development timelines, offering both integrated services and full-service outsourced solutions to complement your in-house efforts.
With extensive expertise in early-stage development, we adopt a pragmatic, fit-for-purpose approach that prioritizes rapid process development while paving the way for future GMP campaigns. For projects requiring scale-up beyond Phase II, we ensure continuity through seamless transitions within our global network, leveraging sister sites and expert teams in the USA and India to meet your long-term manufacturing needs.